AzTrials
AzTrials

Test AnxietyNCT05481099

Reducing Test Anxiety in High School Students

A study testing Intervention in people with Test Anxiety, run by Agrupamento de Centros de Saúde de Dão Lafões at 1 site in Portugal.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

School-age test anxiety is an important risk factor for school performance. Notwithstanding, few studies seek to identify which strategies are effective in improving test anxiety. This study aimed to test whether a cognitive-behavioural intervention for high school students could significantly reduce test anxiety. Read more about this study

Who is it for?
Any ageHealthy volunteers can take part
Conditions the study is for
Test Anxiety
What is being tested?
Intervention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
519 participants
Where
1 sitePortugal
Study dates
1 Dec 2019to 10 Mar 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • 10th grade students; both students and parents provide written informed consent

Who cannot join

  • cognitive inability to answer the questionnaire and/or to participate in the intervention

Trial locations and contacts

1 site in 1 country.

Portugal1 site
  • Alves Martins High School

    Viseu

Other trials in Portugal

About this study

Official title: Efficacy of a Cognitive Behavioural-based Intervention in Reducing Test Anxiety in High School Students: a Pilot Cluster Randomized Controlled Trial

School-age test anxiety is an important risk factor for school performance. Notwithstanding, few studies seek to identify which strategies are effective in improving test anxiety. This study aimed to test whether a cognitive-behavioural intervention for high school students could significantly reduce test anxiety.

A two-arm, cluster-randomized controlled, unblinded, parallel, trial was conducted. Participants were students of the 10th year of the Alves Martins High School in Viseu, Portugal. Students were randomized at class level to receive a cognitive-behavioural-based intervention combined with mindfulness, psychoeducation, and relaxation techniques, or to a control group with no intervention. Participants' anxiety levels were measured using the Test Anxiety Questionnaire. The analysis of the effect of the intervention was carried out on an intention-to-treat basis at the class level, using multilevel mixed effects models and Bayesian modelling.

Conditions
Test Anxiety
Being tested
Intervention

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • InterventionBehavioural

    Cognitive-behavioural-based intervention combined with mindfulness (attention focus), psychoeducation, and relaxation techniques (short version of Jacobson's progressive relaxation, breathing exercises)

Study groups in NCT05481099
Study groupRoleWhat they receive
InterventionExperimentalCognitive-behavioural-based intervention combined with mindfulness, psychoeducation, and relaxation techniques
Receives: Behavioral: Intervention
ControlNo interventionCare as usual

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Test anxiety

    Participants' test anxiety will be assessed using the Test Anxiety Questionnaire. Scores on the questionnaire range from 10 to 50 points. Higher scores mean higher anxiety levels.

    Measured: 12 weeks

Secondary outcomes (2)
  1. Worry

    Participants' worry will be assessed using the Worry subscale (items 1-5) of the Test Anxiety Questionnaire. Scores on the questionnaire range from 5 to 25 points. Higher scores mean higher worry-related anxiety levels.

    Measured: 12 weeks

  2. Emotionality

    Participants' emotionality will be assessed using the Emotionality subscale (items 6-10) of the Test Anxiety Questionnaire. Scores on the questionnaire range from 5 to 25 points. Higher scores mean higher emotionality-related anxiety levels.

    Measured: 12 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Aug 2022
  2. Study start1 Dec 2019
  3. Primary completion10 Mar 2020
  4. Study completion10 Mar 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
519 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05481099
Sponsor's protocol ID
Anxiety-2020
Status last verified
Jul 2022
First submitted
27 Jul 2022
Last updated
1 Aug 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Lopes D, Ferrao A, Matanca AF, Almeida C, Rosario F, Santos J, Santos MI. [A Cognitive Behavioural-Based Intervention in Reducing Test Anxiety in High School Students: A Pilot Cluster Randomized Controlled Trial]. Acta Med Port. 2024 Feb 5;37(3):163-171. doi: 10.20344/amp.18876. Epub 2023 Mar 20. Portuguese.

    PubMed 36939679

Questions about this trial

What is this clinical trial studying?

A study testing Intervention in people with Test Anxiety, run by Agrupamento de Centros de Saúde de Dão Lafões at 1 site in Portugal.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 1 Aug 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Portugal. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Test anxiety (time frame: 12 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05481099, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Aug 2022.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in